RE:RE:RE:Plausible scenarios What I was assuming Rumpl3 is that they may be allowed to recover "cost" without adding profit margin, with a BTD. But you're probably right. Given the recent FDA action to tighten the AA program, I hope it doesn't impact TLT in terms of heavier than usual and longer than usual testing requirements. Critical shortage of BCG will hopefully play into the decision. Let's all hope for BTD soon, before any raise. Best.